Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma.
CompletedOBSERVATIONAL
Enrollment
30
Participants
Timeline
Start Date
March 31, 2005
Primary Completion Date
February 28, 2017
Study Completion Date
February 28, 2017
Conditions
Nasopharyngeal Carcinoma
Trial Locations (1)
M5G 2M9
Princess Margaret Hospital, University Health Network, Toronto
All Listed Sponsors
lead
University Health Network, Toronto
OTHER
NCT00188253 - Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma. | Biotech Hunter | Biotech Hunter